Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CD247/CD3Z Polyclonal Antibody

Catalog #:   PHD44101 Specific References (21) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P20963
Overview

Catalog No.

PHD44101

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CD247/CD3Z (Arg52-Arg164).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

CD3Z, CD247, TCRZ, T-cell receptor T3 zeta chain, T3Z, T-cell surface glycoprotein CD3 zeta chain

Purification

Purified by antigen affinity column.

Accession

P20963

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Various lysates were subjected to SDS PAGE followed by western blot with CD247 antibody (PHD44101) at 1µg/ml.

    Lane 1: Jurkat cell lysate

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 19 kDa
    Observed MW: 16 kDa
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CD247/CD3Z antibody (PHD44101) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 41 kDa
    Observed MW: 41 kDa
References

Risk of celiac disease autoimmunity is modified by interactions between CD247 and environmental exposures., PMID:39462122

Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro., PMID:39392082

Nonsense CD247 mutations show dominant-negative features in T-cell receptor expression and function., PMID:38992472

Identification of a Fully Human Antibody VH Domain Targeting Anaplastic Lymphoma Kinase (ALK) with Applications in ALK-Positive Solid Tumor Immunotherapy., PMID:38804307

Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis., PMID:37868834

Advances in the study of CD47-based bispecific antibody in cancer immunotherapy., PMID:35575882

Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3+ NK Cell Subset with a Bcl11b-Regulated T Cell Signature., PMID:34625521

CAR T-cell therapy for multiple myeloma: state of the art and prospects., PMID:34048683

The Role of CD247 Polymorphisms in Bulgarian Patients with Systemic Lupus Erythematosus., PMID:30064597

Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell., PMID:29790821

Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab., PMID:27178742

TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis., PMID:27118209

Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance., PMID:26286066

Expression pattern of T-helper 17 cell signaling pathway and mucosal inflammation in celiac disease., PMID:24325470

Down regulation of T cell receptor expression in COPD pulmonary CD8 cells., PMID:23977094

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis., PMID:22440820

Association of CD247 with systemic lupus erythematosus in Asian populations., PMID:22004975

Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia., PMID:21044363

Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma., PMID:20029417

Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2., PMID:18089830

Profiling lymphocyte subpopulations in peripheral blood under efalizumab treatment of psoriasis by multi epitope ligand cartography (MELC) robot microscopy., PMID:17229602

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CD247/CD3Z Polyclonal Antibody [PHD44101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only